who developed semaglutide India’s GLP-1 moment is here., With patent expiries, Semaglutide—the molecule behind Ozempic and Wegovy—has entered a new era of access., From ₹28,000 to nearly ₹3,000, this isn’t a compromise in How Semaglutide is Made: Enhanced

It was launched in 2022 but is considered less effective than the blockbuster injectibles.India had the third largest number of people with obesity as of 2022, behind China and the US, according to a study in The Lancet, with numbers surging as junk food consumption becomes more commonplace

weight lifting) or tissue damage and is responsible for muscle hypertrophy

While medications like Ozempic may help some people jumpstart weight loss, theyre not the onlyor the bestpath for everyone

None of the above funding sources were involved in the preparation of this paper

liraglutide alone, attributing the findings to a more gradual dose escalation with IDegLira [48]